Glutathione and glutathione peroxidase expression in breast cancer: An immunohistochemical and molecular study

The use of prognostic markers for breast cancer allows therapeutic strategies to be defined more efficiently. The expression of glutathione (GSH) and glutathione peroxidase (GPX) in tumor cells has been evaluated as a predictor of prognosis and response to cytotoxic treatments. Its immunoexpression...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncology reports 2013-09, Vol.30 (3), p.1119-1128
Hauptverfasser: JARDIM, BRUNA VICTORASSO, MOSCHETTA, MARINA GOBBE, LEONEL, CAMILA, GELALETI, GABRIELA BOTTARO, REGIANI, VITOR RAFAEL, FERREIRA, LÍVIA CARVALHO, LOPES, JULIANA RAMOS, DE CAMPOS ZUCCARI, DEBORA AP. PIRES
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The use of prognostic markers for breast cancer allows therapeutic strategies to be defined more efficiently. The expression of glutathione (GSH) and glutathione peroxidase (GPX) in tumor cells has been evaluated as a predictor of prognosis and response to cytotoxic treatments. Its immunoexpression was assessed in 63 women diagnosed with invasive ductal carcinoma in a retrospective study. The results showed that high GSH expression was associated with tumors negative for the estrogen receptor (ER) (P
ISSN:1021-335X
1791-2431
DOI:10.3892/or.2013.2540